Legal & General Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Buy
313,804
+54,837
+21% +$1.99M ﹤0.01% 1120
2025
Q1
$9.38M Buy
258,967
+160,235
+162% +$5.8M ﹤0.01% 1161
2024
Q4
$4.15M Buy
98,732
+5,896
+6% +$248K ﹤0.01% 1666
2024
Q3
$5.16M Buy
92,836
+7,461
+9% +$414K ﹤0.01% 1558
2024
Q2
$3.51M Buy
85,375
+1,506
+2% +$61.9K ﹤0.01% 1708
2024
Q1
$3.92M Buy
83,869
+11,037
+15% +$515K ﹤0.01% 1635
2023
Q4
$3.48M Buy
72,832
+3,899
+6% +$186K ﹤0.01% 1694
2023
Q3
$2.46M Sell
68,933
-37,978
-36% -$1.35M ﹤0.01% 1803
2023
Q2
$4.93M Sell
106,911
-7,423
-6% -$342K ﹤0.01% 1464
2023
Q1
$4.58M Buy
114,334
+25,213
+28% +$1.01M ﹤0.01% 1460
2022
Q4
$4.13M Buy
89,121
+4,638
+5% +$215K ﹤0.01% 1510
2022
Q3
$3.5M Buy
84,483
+7,314
+9% +$303K ﹤0.01% 1563
2022
Q2
$4.6M Buy
77,169
+2,269
+3% +$135K ﹤0.01% 1450
2022
Q1
$5.44M Buy
74,900
+5,636
+8% +$409K ﹤0.01% 1475
2021
Q4
$5.83M Buy
69,264
+3,513
+5% +$295K ﹤0.01% 1488
2021
Q3
$5.93M Buy
65,751
+16,133
+33% +$1.46M ﹤0.01% 1455
2021
Q2
$4.73M Buy
49,618
+29
+0.1% +$2.77K ﹤0.01% 1561
2021
Q1
$5.65M Sell
49,589
-528
-1% -$60.1K ﹤0.01% 1502
2020
Q4
$6.94M Buy
50,117
+5,856
+13% +$811K ﹤0.01% 1309
2020
Q3
$3.64M Sell
44,261
-2,805
-6% -$231K ﹤0.01% 1503
2020
Q2
$3.68M Buy
47,066
+7,875
+20% +$616K ﹤0.01% 1450
2020
Q1
$1.74M Sell
39,191
-2,557
-6% -$113K ﹤0.01% 1647
2019
Q4
$1.78M Buy
41,748
+6,692
+19% +$286K ﹤0.01% 1855
2019
Q3
$1.5M Buy
35,056
+4,417
+14% +$188K ﹤0.01% 1843
2019
Q2
$1.95M Buy
30,639
+843
+3% +$53.5K ﹤0.01% 1704
2019
Q1
$2.07M Buy
29,796
+9,109
+44% +$632K ﹤0.01% 1687
2018
Q4
$899K Buy
20,687
+3,308
+19% +$144K ﹤0.01% 1937
2018
Q3
$1.33M Buy
17,379
+1,403
+9% +$107K ﹤0.01% 1867
2018
Q2
$1.23M Sell
15,976
-4,450
-22% -$342K ﹤0.01% 1856
2018
Q1
$1.04M Sell
20,426
-131,906
-87% -$6.73M ﹤0.01% 1873
2017
Q4
$7.07M Buy
152,332
+134,407
+750% +$6.24M 0.01% 916
2017
Q3
$957K Buy
17,925
+2,843
+19% +$152K ﹤0.01% 1880
2017
Q2
$933K Buy
15,082
+2,212
+17% +$137K ﹤0.01% 1849
2017
Q1
$870K Buy
12,870
+448
+4% +$30.3K ﹤0.01% 1845
2016
Q4
$873K Buy
12,422
+5,010
+68% +$352K ﹤0.01% 1792
2016
Q3
$516K Sell
7,412
-807
-10% -$56.2K ﹤0.01% 1679
2016
Q2
$402K Hold
8,219
﹤0.01% 1437
2016
Q1
$502K Buy
8,219
+1,063
+15% +$64.9K ﹤0.01% 1310
2015
Q4
$802K Hold
7,156
﹤0.01% 1211
2015
Q3
$664K Buy
7,156
+706
+11% +$65.5K ﹤0.01% 1225
2015
Q2
$641K Buy
6,450
+4,071
+171% +$405K ﹤0.01% 1254
2015
Q1
$151K Buy
2,379
+1,078
+83% +$68.4K ﹤0.01% 1799
2014
Q4
$58K Hold
1,301
﹤0.01% 2346
2014
Q3
$76K Buy
+1,301
New +$76K ﹤0.01% 2104